$347 Million is the total value of Wildcat Capital Management, LLC's 31 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 51.7% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ZM | New | ZOOM VIDEO COMMUNICATIONS INcl a | $77,549,000 | – | 1,139,755 | +100.0% | 22.37% | – |
CSGP | Sell | COSTAR GROUP INC | $58,270,000 | -7.8% | 97,392 | -8.6% | 16.81% | -37.4% |
URGN | Buy | UROGEN PHARMA LTD | $38,571,000 | +53.3% | 1,155,862 | +9.5% | 11.13% | +4.1% |
ALLO | Buy | ALLOGENE THERAPEUTICS INC | $31,223,000 | +26.4% | 1,201,826 | +32.6% | 9.01% | -14.2% |
BKNG | BOOKING HOLDINGS INC | $14,091,000 | +4.6% | 6,861 | 0.0% | 4.06% | -28.9% | |
FB | FACEBOOK INCcl a | $13,660,000 | +15.3% | 66,553 | 0.0% | 3.94% | -21.7% | |
SBR | SABINE ROYALTY TRunit ben int | $13,424,000 | -7.3% | 335,564 | 0.0% | 3.87% | -37.0% | |
MGY | Sell | MAGNOLIA OIL & GAS CORPcl a | $10,756,000 | +8.0% | 854,997 | -4.7% | 3.10% | -26.7% |
GWRE | GUIDEWIRE SOFTWARE INC | $9,964,000 | +4.2% | 90,768 | 0.0% | 2.87% | -29.3% | |
HYG | New | ISHARES TRiboxx hi yd etf | $9,643,000 | – | 110,120 | +100.0% | 2.78% | – |
PAGS | Buy | PAGSEGURO DIGITAL LTD | $8,700,000 | +104.3% | 254,686 | +177.0% | 2.51% | +38.8% |
EMB | Sell | ISHARES TRjpmorgan usd emg | $8,012,000 | -7.1% | 70,189 | -8.4% | 2.31% | -36.9% |
LQD | Sell | ISHARES TRiboxx inv cp etf | $7,840,000 | -16.1% | 61,428 | -16.6% | 2.26% | -43.0% |
GSHD | Buy | GOOSEHEAD INS INC | $7,525,000 | +4.4% | 177,478 | +21.5% | 2.17% | -29.1% |
VYM | Buy | VANGUARD WHITEHALL FDS INChigh div yld | $5,398,000 | +73.9% | 57,607 | +64.7% | 1.56% | +18.0% |
MUB | Sell | ISHARES TRnational mun etf | $5,003,000 | -0.0% | 44,000 | -0.1% | 1.44% | -32.1% |
CCJ | CAMECO CORP | $4,450,000 | -6.3% | 500,000 | 0.0% | 1.28% | -36.4% | |
OPTN | Sell | OPTINOSE INC | $3,611,000 | -0.5% | 391,607 | -24.4% | 1.04% | -32.4% |
UROV | UROVANT SCIENCES LTD | $3,412,000 | +63.8% | 219,975 | 0.0% | 0.98% | +11.2% | |
NCNA | NUCANA PLCsponsored adr | $3,218,000 | -15.7% | 527,487 | 0.0% | 0.93% | -42.8% | |
GGAL | New | GRUPO FINANCIERO GALICIA S Asponsored adr | $2,765,000 | – | 170,379 | +100.0% | 0.80% | – |
AQST | New | AQUESTIVE THERAPEUTICS INC | $2,650,000 | – | 455,358 | +100.0% | 0.76% | – |
YPF | New | YPF SOCIEDAD ANONIMAspon adr cl d | $2,579,000 | – | 222,685 | +100.0% | 0.74% | – |
PLYA | PLAYA HOTELS & RESORTS NV | $2,520,000 | +7.3% | 300,000 | 0.0% | 0.73% | -27.2% | |
GWPH | GW PHARMACEUTICALS PLCads | $732,000 | -9.1% | 7,000 | 0.0% | 0.21% | -38.3% | |
ENTX | Sell | ENTERA BIO LTD | $384,000 | -20.2% | 179,526 | -7.1% | 0.11% | -45.6% |
New | UNITED STATES NATL GAS FUNDcall | $260,000 | – | 294,000 | +100.0% | 0.08% | – | |
New | ISHARES TRput | $210,000 | – | 20,400 | +100.0% | 0.06% | – | |
New | BARCLAYS BK PLCcall | $132,000 | – | 191,400 | +100.0% | 0.04% | – | |
NH | NANTHEALTH INC | $84,000 | +42.4% | 81,870 | 0.0% | 0.02% | -4.0% | |
Exit | ISHARES INCcall | $0 | – | -80,400 | -100.0% | -0.03% | – | |
Exit | ISHARES INCput | $0 | – | -92,000 | -100.0% | -0.04% | – | |
Exit | ISHARES TRcall | $0 | – | -111,800 | -100.0% | -0.08% | – | |
GRTS | Exit | GRITSTONE ONCOLOGY INC | $0 | – | -23,902 | -100.0% | -0.09% | – |
NK | Exit | NANTKWEST INC | $0 | – | -492,000 | -100.0% | -0.26% | – |
TLT | Exit | ISHARES TR20 yr tr bd etf | $0 | – | -21,544 | -100.0% | -1.30% | – |
WORK | Exit | SLACK TECHNOLOGIES INC- CL A | $0 | – | -136,558 | -100.0% | -1.38% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
COSTAR GROUP INC | 32 | Q3 2022 | 48.3% |
UROGEN PHARMA LTD | 26 | Q3 2023 | 17.3% |
META PLATFORMS INC | 26 | Q3 2023 | 9.9% |
ALLOGENE THERAPEUTICS INC | 18 | Q3 2023 | 22.4% |
GOOSEHEAD INSURANCE INC -A | 18 | Q3 2023 | 15.4% |
SABINE RTY TRUST | 18 | Q3 2021 | 11.3% |
LPL FINL HLDGS INC | 18 | Q1 2019 | 12.7% |
PLAYA HOTELS & RESORTS NV | 18 | Q3 2021 | 3.4% |
NANTKWEST INC | 17 | Q3 2019 | 22.0% |
SORRENTO THERAPEUTICS INC | 17 | Q2 2019 | 7.0% |
View Wildcat Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Skillz Inc. | January 05, 2023 | 19,596,988 | 5.6% |
UroGen Pharma Ltd. | February 14, 2022 | 533,139 | 2.4% |
Skillz Inc. | March 08, 2021 | 21,832,022 | 7.5% |
NantKwest, Inc. | February 13, 2018 | 808,974 | 1.0% |
Sorrento Therapeutics, Inc. | February 13, 2018 | 1,738,232 | 2.2% |
View Wildcat Capital Management, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
3 | 2024-04-08 |
SC 13G | 2024-04-08 |
13F-HR | 2024-02-13 |
13F-HR | 2023-11-09 |
PX14A6G | 2023-11-03 |
13F-HR | 2023-08-11 |
13F-HR/A | 2023-08-10 |
13F-HR | 2023-05-12 |
13F-HR | 2023-02-07 |
SC 13D/A | 2023-01-05 |
View Wildcat Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.